|
1
|
Woods WG: Curing childhood acute myeloid
leukemia (AML) at the half-way point: promises to keep and miles to
go before we sleep. Pediatr Blood Cancer. 46:565–569. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Creutzig U, Zimmermann M, Reinhardt D,
Dworzak M, Stary J and Lehrnbecher T: Early deaths and
treatment-related mortality in children undergoing therapy for
acute myeloid leukemia: analysis of the multicenter clinical trials
AML-BFM93 and AML-BFM 98. J Clin Oncol. 22:4384–4393. 2004.
View Article : Google Scholar
|
|
3
|
Pui CH, Carroll WL, Meshinchi S and Arceci
RJ: Biology, risk stratification, and therapy of pediatric acute
leukemias: an update. J Clin Oncol. 29:551–565. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Rubnitz JE and Inaba H: Childhood acute
myeloid leukemia. Br J Haematol. 159:259–276. 2012. View Article : Google Scholar
|
|
5
|
Rocchi P, Beraldi E, Ettinger S, Fazli L,
Vessella RL, Nelson C and Gleave M: Increased Hsp27 after androgen
ablation facilitates androgen-independent progression in prostate
cancer via signal transducers and activators of transcription
3-mediated suppression of apoptosis. Cancer Res. 65:11083–11093.
2005. View Article : Google Scholar
|
|
6
|
Love S and King RJ: A 27 kDa heat shock
protein that has anomalous prognostic powers in early and advanced
breast cancer. Br J Cancer. 69:743–748. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huang Q, Ye J, Chen W, et al: Heat shock
protein 27 is overexpressed in tumor tissues and increased in sera
of patients with gastric adenocarcinoma. Clin Chem Lab Med.
48:263–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Langdon SP, Rabiasz GJ, Hirst GL, King RJ,
Hawkins RA, Smyth JF and Miller WR: Expression of the heat shock
protein Hsp27 in human ovarian cancer. Clin Cancer Res.
1:1603–1609. 1995.PubMed/NCBI
|
|
9
|
Lebret T, Watson RW, Molinié V, O’Neill A,
Gabriel C, Fitzpatrick JM and Botto H: Heat shock proteins Hsp27,
Hsp60, Hsp70, and Hsp90: expression in bladder carcinoma. Cancer.
98:970–977. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Melle C, Ernst G, Escher N, et al: Protein
profiling of microdissected pancreas carcinoma and identification
of Hsp27 as a potential serum marker. Clin Chem. 53:629–635. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yu Z, Zhi J, Peng X, Zhong X and Xu A:
Clinical significance of Hsp27 expression in colorectal cancer. Mol
Med Rep. 3:953–958. 2010.PubMed/NCBI
|
|
12
|
Tweedle EM, Khattak I, Ang CW, et al: Low
molecular weight heat shock protein HSP27 is a prognostic indicator
in rectal cancer but not colon cancer. Gut. 59:1501–1510. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang F, Zhang P, Shi C, Yang Y and Qin H:
Immunohistochemical detection of Hsp27 and hnRNP K as prognostic
and predictive biomarkers for colorectal cancer. Med Oncol.
29:1780–1788. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang YX, Xiao ZQ, Chen ZC, et al: Proteome
analysis of multidrug resistance in vincristine-resistant human
gastric cancer cell line SGC7901/VCR. Proteomics. 6:2009–2021.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andrieu C, Taieb D, Baylot V, et al: Heat
shock protein 27 confers resistance to androgen ablation and
chemotherapy in prostate cancer cells through eIF4E. Oncogene.
29:1883–1896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Havasi A, Li Z, Wang Z, et al: Hsp27
inhibits Bax activation and apoptosis via a phosphatidylinositol
3-kinase-dependent mechanism. J Biol Chem. 283:12305–12313. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
O’Callaghan-Sunol C, Gabai VL and Sherman
MY: Hsp27 modulates p53 signaling and suppresses cellular
senescence. Cancer Res. 67:11779–11788. 2007.PubMed/NCBI
|
|
18
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposed revised
criteria for the classification of acute myeloid leukemia: a report
of the French-American-British Cooperative Group. Ann Intern Med.
103:620–625. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cheson BD, Cassileth PA, Head DR, et al:
Report of the National Cancer Institute sponsored workshop on
definitions of diagnosis and response in acute myeloid leukemia:
review. J Clin Oncol. 8:813–819. 1990.PubMed/NCBI
|
|
20
|
Yang L, Yu Y, Kang R, et al: Up-regulated
autophagy by endogenous high mobility group box-1 promotes
chemoresistance in leukemia cells. Leuk Lymphoma. 53:315–322. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang L, Yang M, Zhang H, et al:
S100A8-targeting siRNA enhances arsenic trioxide-induced myeloid
leukemia cell death by downregulating autophagy. Int J Mol Med.
29:65–72. 2012.PubMed/NCBI
|
|
22
|
Garrido C, Ottavi P, Fromentin A, Hammann
A, Arrigo AP, Chauffert B and Mehlen P: Hsp27 as a mediator of
confluence-dependent resistance to cell death induced by anticancer
drugs. Cancer Res. 57:2661–2267. 1997.PubMed/NCBI
|
|
23
|
Williams K, Chubb C, Huberman E and
Giometti CS: Analysis of differential protein expression in normal
and neoplastic human breast epithelial cell lines. Electrophoresis.
19:333–343. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Myung JK, Afjehi-Sadat L,
Felizardo-Cabatic M, Slavc I and Lubec G: Expressional patterns of
chaperones in ten human tumor cell lines. Proteome Sci. 2:82004.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Ciocca DR, Oesterreich S, Chamness GC,
McGuire WL and Fuqua SA: Biological and clinical implications of
heat shock protein 27,000 (Hsp27): a review. J Natl Cancer Inst.
85:1558–1570. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen GY and Nuñez G: Sterile inflammation:
sensing and reacting to damage. Nat Rev Immunol. 10:826–837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaspers GJ and Creutzig U: Pediatric acute
myeloid leukemia: international progress and future directions.
Leukemia. 19:2025–2029. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Molgaard-Hansen L, Glosli H, Jahnukainen
K, et al: Quality of health in survivors of childhood acute myeloid
leukemia treated with chemotherapy only: A NOPHO-AML study. Pediatr
Blood Cancer. 57:1222–1229. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Jo A, Tsukimoto I, Ishii E, Asou N, et al:
Age-associated difference in gene expression of paediatric acute
myelomonocytic lineage leukaemia (FAB M4 and M5 subtypes) and its
correlation with prognosis. Br J Haematol. 144:917–929. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ravindranath Y, Chang M, Steuber CP, et
al: Pediatric Oncology Group (POG) studies of acute myeloid
leukemia (AML): a review of four consecutive childhood AML trials
conducted between 1981 and 2000. Leukemia. 19:2101–2116. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Estey E and Dohner H: Acute myeloid
leukaemia. Lancet. 368:1894–1907. 2006. View Article : Google Scholar
|
|
32
|
Dutcher JP, Schiffer CA and Wiernik PH:
Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on
remission rate and duration, and survival. J Clin Oncol.
5:1364–1372. 1987.PubMed/NCBI
|
|
33
|
Ross DD: Novel mechanisms of drug
resistance in leukemia. Leukemia. 14:467–473. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mori-Iwamoto S, Kuramitsu Y, Ryozawa S, et
al: Proteomics finding heat shock protein 27 as a biomarker for
resistance of pancreatic cancer cells to gemcitabine. Int J Oncol.
31:1345–1350. 2007.PubMed/NCBI
|
|
35
|
Choi DH, Ha JS, Lee WH, et al: Heat shock
protein 27 is associated with irinotecan resistance in human
colorectal cancer cells. FEBS Lett. 581:1649–1656. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lanneau D, Brunet M, Frisan E, Solary E,
Fontenay M and Garrido C: Heat shock proteins: essential proteins
for apoptosis regulation. J Cel Mol Med. 12:743–761. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Voss OH, Batra S, Kolattukudy SJ,
Gonzalez-Mejia ME, Smith JB and Doseff AI: Binding of caspase-3
prodomain to heat shock protein 27 regulates monocyte apoptosis by
inhibiting caspase-3 proteolytic activation. J Biol Chem.
282:25088–25099. 2007. View Article : Google Scholar : PubMed/NCBI
|
